top of page

Polynucleotide treatment: what it is, what it may do, and what to expect

Ariana Wen

August 13, 2026

Polynucleotide treatment: what it is, what it may do, and what to expect

Key takeaways


Polynucleotide and polydeoxyribonucleotide have different molecular features. Products include topicals and injectables, while injection methods and treatment areas vary. Results for wrinkles, texture, and elasticity look promising, but high-quality research is still needed.


Polynucleotide treatment can feel confusing. One broad label can appear on a cream, serum, mask, gel, or injection. The molecular terms can vary too.


Polynucleotide and polydeoxyribonucleotide are related, but their length and function differ. For a clear comparison, note the molecule, product form, treatment area, result, and follow-up time. This is helpful for facial and under-eye concerns, where one narrow result can sound much broader than it is.


The shared name is only the start of the answer. The rest comes from the full product and the job it was used to do. That detail can turn a vague promise into something you can weigh with more confidence.


The polynucleotide label covers different molecules and product forms


At the broadest level, polynucleotides are complex molecules made of nucleotides. The word names a molecular family, while the product form tells you how that material is used. A cream and an injection can share the family label while remaining different forms.


A label decoder separates molecular identity, longer polynucleotide or shorter polydeoxyribonucleotide, from topical or injectable product form.

There is a second difference within this family. Both long molecular names refer to DNA-derived biopolymers, but their roles differ with length and weight. The longer form plays a role in remodelling the material that supports cells.


Polydeoxyribonucleotide has shorter sequences than polynucleotide. It is linked with adenosine-receptor activation and with nucleotide production through salvage and de novo pathways. These features make the two long names more than spelling variations.


Medical writing has sometimes used both terms for polymers of different lengths, which has caused confusion. The full product description gives you more useful detail than a short family label.


Label or form

What it identifies

Defining feature

Polynucleotide

A DNA-derived biopolymer

Longer DNA fragments linked with extracellular-matrix remodelling

Polydeoxyribonucleotide

A related DNA-derived biopolymer

Relatively shorter sequences with different associated functions

Topical formats

Products placed on the skin

Commercial forms include gels, creams, serums, and masks

Injectables

Products delivered by injection

Injection area and technique can vary


An injection can vary by both area and technique. A result from an under-eye injection describes that area and method, while a cream remains a different product form.


A useful product description has four parts. First comes the molecular label, followed by a form such as a serum or injection. For an injection, the treatment area and technique complete the picture.


This fuller description helps with real choices. A serum claim should tell you about that serum, and an under-eye injection result should name that area. The family name on its own leaves those useful details open.


The same reading works in the other direction. When a result names an injection, you know the finding came from an injected form. When it names the lower eyelid, you know the measured area. This keeps the product description close to the skin concern you are trying to understand.


Long molecular names can look like the most important part of the label. In practice, the form and treatment area often make the result easier to place. They tell you whether you are reading about skin care placed on the surface or a procedure delivered into the skin.


What can polynucleotide injections do to the skin?


Polynucleotide injections have produced promising findings for wrinkles, skin texture, and elasticity. Several studies found statistically significant changes in these areas. Hydration has also been measured, although results across aesthetic research have been mixed.


The best broad snapshot here includes nine low- or moderate-quality studies and 219 patients. The paper calls the treatment category PN. Some studies found clear gains in elasticity and hydration, while others found little or no benefit.


Wrinkles, texture, elasticity, and hydration were measured as specific skin concerns. A result is most useful when it matches the change you care about.


For one specific product, a water-attracting, scaffold-like matrix may support tissue remodelling and hydration. This is a proposed way that product may work. Other forms and products can have their own features.


Promising changes have been reported for wrinkles, texture, and elasticity. At the same time, the best aesthetic use is still unclear. Stronger studies are needed to test how well these injections work and how safe they are. The product uses described by expert opinion also need random trials and tissue-level checks.


The practical answer is hopeful but focused. These injection findings include changes in texture, elasticity, hydration, and fine lines. The exact product, area, and result shape what they mean for you.


If you are comparing other skin-quality procedures, our pages on skin booster injections and microneedling describe those ReJoo Clinic services.


The quality of the work matters too. Low- or moderate-quality studies can offer an early signal, but they leave more room for doubt. That is why the promising findings and the call for stronger work belong in the same answer.


What do before-and-after measurements show under the eyes?


One case series followed 42 people who received an absorbable under-eye injection. The product was Pluryal Silk at 7.5 mg/mL. Each session used 2 mL within the skin.


The group had checks at one, three, and six months. Lower-eyelid and crow's-feet appraisal scores improved significantly at every check compared with the starting scores. The change appeared in both rated areas.


These scores covered the lower eyelid and crow's-feet. The case gives a full picture of the setup: product, strength, volume, group size, two rated areas, and three follow-up points. That is more useful than a broad before-and-after promise.


This was an observational case with one product, so it offers a useful under-eye signal. The named areas and check-in times give "improvement" a clear meaning. They also identify the exact injection behind the scores.


How long do under-eye polynucleotide results last?


The clearest point from the 42-person case is three months. The greatest gains and highest patient satisfaction came then, after two sessions. This was the peak within checks at one, three, and six months.


At six months, lower-eyelid and crow's-feet scores were still better than their starting scores. This result came from the same product and group. It shows what was measured at that check.


A separate estimate says under-eye results may last around 6 to 12 months. The range can vary with lifestyle, skin type, and skin care. It gives a window for under-eye results, not a fixed date.


Three months marks the peak in one case, while 6 to 12 months estimates how long results may last. For a useful duration, keep the area and result beside the number. That is the clearest answer to "How long does polynucleotide treatment last?"


What are the common side effects of polynucleotide injections?


Common short-term injection-site effects include mild swelling, small temporary bumps, and light redness, which usually settle within 24 to 48 hours. This short window can still matter when you want your skin to look settled.


Across the nine low- or moderate-quality studies, side effects were generally mild and temporary, and patient satisfaction was moderate to high. Stronger work is still needed to test both safety and results.


The 42-patient under-eye case series recorded minimal adverse events. That was the experience with its named absorbable product and under-eye setup.


Complete candidacy rules, reasons to avoid treatment, and uncommon risks need product-specific details. The findings here do not provide that full picture.


A mild reaction can still feel noticeable when it is on your face. Clear names make the short-term picture easier to understand: swelling, small bumps, and light redness are the common effects described. The wider safety question still needs stronger research and details for the exact product.


The under-eye series and the broader group of studies point to a generally mild short-term pattern. They also have limits. One followed 42 people with a named product, while the broader set contained studies of low or moderate quality.


Preparation and aftercare have their own time windows


Preparation starts with a simple skin-care base. A cleanser, moisturizer, and broad-spectrum SPF 50+ routine is recommended two to four weeks before an aesthetic procedure. In this advice, these injections sit with procedures that leave the skin barrier intact.


After treatment, avoid strenuous exercise for 24 hours. The same aftercare information sets a two-week break from other injectable treatments. These time windows apply to the actions named with them.


Also avoid direct sun exposure and harsh skin-care actives after treatment, and use SPF 50 each day.


If your concern is broader than one treatment label, our skin consultation in North York offers a concern-based starting point.


The order is easy to follow when you place it around the procedure date. The basic skin-care routine begins in the weeks before treatment. Exercise and other injections have their stated pauses afterward, while sun care and gentle product choices remain part of the aftercare directions.


These steps cover ordinary preparation and recovery care. A named product may come with more detail, so this short list should be read as the category-level guidance available here.


Under-eye treatments have structural and skin-quality roles


The under-eye area can involve more than one goal. Around the eyes, hyaluronic-acid fillers have stronger support for structural correction. Findings for these other injections centre on skin quality.


Hyaluronic-acid fillers

Polynucleotide injections

Structural correction around the eyes

Changes measured in elasticity, hydration, and fine wrinkles


The table compares roles, not which option comes first. Your concern may involve both roles, but a hydration or fine-wrinkle result is a skin-quality result. If structural correction is your concern, our dermal fillers page describes that ReJoo Clinic service.


Facial polynucleotide plans vary by area and product technology


A facial plan varies with the area and product, and expert consensus for one natural-origin, highly purified technology used the label PN-HPT. More than 80% agreed on its use for the face and eye area. The work also covered the neck, upper chest, hands, scalp, and stretch marks.


Advice changed by area. It covered injection method, dose, volume, number of sessions, and time between sessions. PN-HPT was described as a booster for skin priming and revitalization of the face and body.


For facial care, look at the named technology and part of the face. The method, amount, session count, and interval complete the plan. The eye area had its own advice within the wider face and body work.


These points give a polynucleotide facial claim a clear frame. A label such as PN-HPT still needs an area and plan. Those details show what the expert agreement covered.


If your real question is about texture, hydration, fine lines, or the under-eye area, begin with our skin consultation page. We can focus on your concern and discuss the ReJoo Clinic services that fit it.

Ready to take the next step?

Book a personalized consultation with our medical team to find the right approach for your skin, health, and goals.

©2026 Rejoo Clinic Inc. All rights reserved.

bottom of page